Twice-daily insulin degludec/insulin aspart effectively improved morning and evening glucose levels and quality of life in patients previously treated with premixed insulin: an observational study

BACKGROUND: Previous studies comparing insulin degludec/insulin aspart (IDegAsp) with premixed insulin twice daily among insulin users with type 2 diabetes have not thoroughly investigated differences in the glucose variability and psychological evaluations related to insulin regimen changes. We inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujimoto, Kanta, Iwakura, Toshio, Aburaya, Megumi, Matsuoka, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097398/
https://www.ncbi.nlm.nih.gov/pubmed/30127860
http://dx.doi.org/10.1186/s13098-018-0366-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097398/
https://www.ncbi.nlm.nih.gov/pubmed/30127860
http://dx.doi.org/10.1186/s13098-018-0366-x

Ejemplares similares